trial

Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)

NCTId NCT03829280
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 205 (actual)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2024-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
205 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-04-04
Primary completion
2024-05-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive Adaptation TrainingCommunity Treatment

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor
Vanguard Research GroupCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dawn I. Velligan, PhDPrincipal Investigator

Sites

8 total
Dayville, United StatesLauderdale Lakes, United StatesGranite City, United StatesLawrenceburg, United StatesManchester, United StatesEugene, United StatesProvidence, United StatesHouston, United States

Facts & assertions

4 sourced
Enrollment
205
Phase
NA
Primary Completion Date
2024-05-31
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Adaptation Training
drug
Community Treatment
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
collaborator
Vanguard Research Group
company
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Dawn I. Velligan, PhD
person